|
|
|
|
| LEADER |
01669nam a2200337 u 4500 |
| 001 |
EB000944133 |
| 003 |
EBX01000000000000000737723 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
150223 r ||| eng |
| 020 |
|
|
|a 0309128676
|
| 020 |
|
|
|a 9780309128674
|
| 050 |
|
4 |
|a R853.C55
|
| 100 |
1 |
|
|a Patlak, Margie
|
| 245 |
0 |
0 |
|a Multi-center phase III clinical trials and NCI cooperative groups
|h Elektronische Ressource
|b workshop summary
|c Margie Patlak, Sharyl Nass, and Christine Micheel, rapporteurs ; National Cancer Policy Forum, Institute of Medicine of the National Academies
|
| 260 |
|
|
|a Washington, D.C.
|b National Academies Press
|c c2009, 2009
|
| 300 |
|
|
|a xii, 121 p.
|b ill.
|c 23 cm
|
| 505 |
0 |
|
|a Includes bibliographical references (p. 97-101)
|
| 505 |
0 |
|
|a Organization of the NCI clinical trials system -- Lessons from non-cooperative group multi-center clinical trials -- Barriers to patient recruitment and physician participation -- Data collection standards and monitoring -- Costs of cooperative group clinical trials
|
| 653 |
|
|
|a United States
|
| 653 |
|
|
|a Multicenter Studies as Topic
|
| 653 |
|
|
|a Clinical Trials, Phase III as Topic
|
| 700 |
1 |
|
|a Nass, Sharyl J.
|
| 700 |
1 |
|
|a Micheel, Christine
|
| 710 |
2 |
|
|a National Cancer Policy Forum (U.S.)
|
| 710 |
2 |
|
|a Institute of Medicine (U.S.)
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK215081
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 856 |
4 |
0 |
|u http://search.nap.edu/nap-cgi/de.cgi?term=0309128676
|3 Volltext
|n Provider site
|3 Volltext
|
| 082 |
0 |
|
|a 610.724
|